Therapeutic RSK1 Targeting in Myelofibrosis
Washington University School of Medicine
Washington University School of Medicine
Nanfang Hospital, Southern Medical University
Stanford University
Eilean Therapeutics
Eilean Therapeutics
University of Turin, Italy
Grupo Español de Enfermedades Mieloproliferativas Crónicas PH Negativas
Brigham and Women's Hospital
Fondazione Policlinico Universitario Agostino Gemelli IRCCS